YolTech Therapeutics
Minhang
About YolTech Therapeutics
Yaotang (Shanghai) Biotechnology is a high-tech biotechnology company focusing on developing a new generation of mRNA drugs and gene editing drugs by combining mRNA in vivo delivery technology and gene editing technology. Through the continuous development and optimization of CRISPR, base editing and other new-generation gene editing tools, and innovative improvements to the next-generation mRNA production platform and lipid nanocarrier assembly process, Yaotang Bio is committed to developing treatments for genetic diseases and cardiovascular disease.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Total funding: $71.0M
- Funding stage: Early Stage Venture
- Last round: Series B (Sep 2025)
- Website: yoltx.com
- Phone: 1-215-226-0086
Industries & Categories
Biopharma, Biotechnology
Social Profiles
Canonical: https://fsome.com/organization/yoltech-therapeutics-105834 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.